Rehák J, Vymazal M
Acta Univ Palacki Olomuc Fac Med. 1989;123:231-6.
Although temporal branch retinal vein occlusion has, on the whole, a good prognosis, in about 40% of the patients the outcoming vision is markedly changed. The authors used argon laser to treat 15 patients suffering from temporal branch retinal vein occlusion. They analyze their experiences and the results of the treatment of chronic macular edema and neovascularizations with argon laser photocoagulation. In 5 of 7 patients with chronic macular edema, they achieved resorption of the edema within 2 months after photocoagulation. They elaborated their own modification of the laser barrage according to L'Esperance. In more than half the patients, treated for chronic macular edema, the achieved visual acuity was 6/6-6/9, the worst vision was 6/18. In none of the patients a decrease in visual acuity occurred. In the management of neovascularizations of the retina and the disc of the optic nerve, argon laser photocoagulation resulted in involution of the neovascularizations in all 3 patients, vitreous hemorrhage did not occur in any of the eyes. Although the group of the treated patients is only small, the authors consider the treatment of the temporal branch retinal vein occlusion with argon laser photocoagulation to be beneficial.
虽然视网膜颞支静脉阻塞总体预后良好,但约40%的患者最终视力会明显改变。作者使用氩激光治疗15例视网膜颞支静脉阻塞患者。他们分析了使用氩激光光凝治疗慢性黄斑水肿和新生血管的经验及结果。在7例慢性黄斑水肿患者中,有5例在光凝治疗后2个月内水肿吸收。他们根据L'Esperance对激光屏障进行了自己的改良。在接受慢性黄斑水肿治疗的半数以上患者中,最终视力为6/6 - 6/9,最差视力为6/18。所有患者视力均未下降。在视网膜和视神经盘新生血管的治疗中,氩激光光凝使所有3例患者的新生血管消退,所有患眼均未发生玻璃体出血。虽然治疗的患者组规模较小,但作者认为用氩激光光凝治疗视网膜颞支静脉阻塞是有益的。